Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Theravance Biopharma (TBPH) Cost of Revenue (2016 - 2018)

Theravance Biopharma (TBPH) has disclosed Cost of Revenue for 5 consecutive years, with $826000.0 as the latest value for Q1 2018.

  • Quarterly Cost of Revenue rose 46.19% to $826000.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Mar 2018, up 134.65% year-over-year, with the annual reading at $6.0 million for FY2017, 108.36% up from the prior year.
  • Cost of Revenue for Q1 2018 was $826000.0 at Theravance Biopharma, down from $3.1 million in the prior quarter.
  • The five-year high for Cost of Revenue was $3.2 million in Q4 2014, with the low at $188000.0 in Q1 2014.
  • Average Cost of Revenue over 5 years is $1.1 million, with a median of $638000.0 recorded in 2016.
  • The sharpest move saw Cost of Revenue plummeted 64.2% in 2016, then soared 196.69% in 2017.
  • Over 5 years, Cost of Revenue stood at $3.2 million in 2014, then fell by 0.65% to $3.2 million in 2015, then tumbled by 64.2% to $1.1 million in 2016, then soared by 171.9% to $3.1 million in 2017, then plummeted by 73.49% to $826000.0 in 2018.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $826000.0, $3.1 million, and $985000.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.